Literature DB >> 25480750

Development of a reverse genetic system for infectious salmon anemia virus: rescue of recombinant fluorescent virus by using salmon internal transcribed spacer region 1 as a novel promoter.

Daniela Toro-Ascuy, Carolina Tambley, Carolina Beltran, Carolina Mascayano, Nicolas Sandoval, Eduardo Olivares, Rafael A Medina, Eugenio Spencer, Marcelo Cortez-San Martín.   

Abstract

Infectious salmon anemia (ISA) is a serious disease of marine-farmed Atlantic salmon (Salmo salar) caused by ISA virus (ISAV), belonging to the genus Isavirus, family Orthomyxoviridae. There is an urgent need to understand the virulence factors and pathogenic mechanisms of ISAV and to develop new vaccine approaches. Using a recombinant molecular biology approach, we report the development of a plasmid-based reverse genetic system for ISAV, which includes the use of a novel fish promoter, the Atlantic salmon internal transcribed spacer region 1 (ITS-1). Salmon cells cotransfected with pSS-URG-based vectors expressing the eight viral RNA segments and four cytomegalovirus (CMV)-based vectors that express the four proteins of the ISAV ribonucleoprotein complex allowed the generation of infectious recombinant ISAV (rISAV). We generated three recombinant viruses, wild-type rISAV(901_09) and rISAVr(S6-NotI-HPR) containing a NotI restriction site and rISAV(S6/EGFP-HPR) harboring the open reading frame of enhanced green fluorescent protein (EGFP), both within the highly polymorphic region (HPR) of segment 6. All rescued viruses showed replication activity and cytopathic effect in Atlantic salmon kidney-infected cells. The fluorescent recombinant viruses also showed a characteristic cytopathic effect in salmon cells, and the viruses replicated to a titer of 6.5105 PFU/ml,similar to that of the wild-type virus. This novel reverse genetics system offers a powerful tool to study the molecular biology of ISAV and to develop a new generation of ISAV vaccines to prevent and mitigate ISAV infection, which has had a profound effect on the salmon industry.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25480750      PMCID: PMC4309705          DOI: 10.1128/AEM.03153-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  58 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

2.  Development of plaque assay for Chilean infectious salmon anaemia virus, application for virus purification and titration in salmon ASK cells.

Authors:  M T Castillo-Cerda; L Cottet; D Toro-Ascuy; E Spencer; M Cortez-San Martín
Journal:  J Fish Dis       Date:  2013-11-08       Impact factor: 2.767

3.  Completion of the full-length genome sequence of the infectious salmon anemia virus, an aquatic orthomyxovirus-like, and characterization of mAbs.

Authors:  Emilie Mérour; Monique LeBerre; Annie Lamoureux; Julie Bernard; Michel Brémont; Stéphane Biacchesi
Journal:  J Gen Virol       Date:  2010-12-01       Impact factor: 3.891

4.  RNA polymerase I catalysed transcription of insert viral cDNA.

Authors:  A Zobel; G Neumann; G Hobom
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

5.  Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.

Authors:  Andrea Rivas-Aravena; Eva Vallejos-Vidal; Marcelo Cortez-San Martin; Felipe Reyes-Lopez; Mario Tello; Patricia Mora; Ana María Sandino; Eugenio Spencer
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

6.  Use of RT-PCR for diagnosis of infectious salmon anaemia virus (ISAV) in carrier sea trout Salmo trutta after experimental infection.

Authors:  M Devold; B Krossøy; V Aspehaug; A Nylund
Journal:  Dis Aquat Organ       Date:  2000-02-24       Impact factor: 1.802

7.  Infectious salmon anemia virus specifically binds to and hydrolyzes 4-O-acetylated sialic acids.

Authors:  Audny Hellebø; Ulrike Vilas; Knut Falk; Reinhard Vlasak
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Molecular and functional characterization of two infectious salmon anaemia virus (ISAV) proteins with type I interferon antagonizing activity.

Authors:  Esther García-Rosado; Turhan Markussen; Oyvind Kileng; Espen S Baekkevold; Børre Robertsen; Siri Mjaaland; Espen Rimstad
Journal:  Virus Res       Date:  2008-03-04       Impact factor: 3.303

9.  Genome rearrangement of influenza virus for anti-viral drug screening.

Authors:  Troy C Sutton; Adebimpe Obadan; Johanna Lavigne; Hongjun Chen; Weizhong Li; Daniel R Perez
Journal:  Virus Res       Date:  2014-05-12       Impact factor: 3.303

10.  Infectious salmon anaemia virus (ISAV) in Chilean Atlantic salmon (Salmo salar) aquaculture: emergence of low pathogenic ISAV-HPR0 and re-emergence of virulent ISAV-HPR∆: HPR3 and HPR14.

Authors:  Marcos G Godoy; Molly J T Kibenge; Rudy Suarez; Eduardo Lazo; Alejandro Heisinger; Javier Aguinaga; Diego Bravo; Julio Mendoza; Katerina O Llegues; Rubén Avendaño-Herrera; Cristian Vera; Fernando Mardones; Frederick S B Kibenge
Journal:  Virol J       Date:  2013-11-23       Impact factor: 4.099

View more
  3 in total

1.  Nanopore sequencing for rapid diagnostics of salmonid RNA viruses.

Authors:  Michael D Gallagher; Iveta Matejusova; Lien Nguyen; Neil M Ruane; Knut Falk; Daniel J Macqueen
Journal:  Sci Rep       Date:  2018-11-05       Impact factor: 4.379

2.  Capsid amino acids at positions 247 and 270 are involved in the virulence of betanodaviruses to European sea bass.

Authors:  Patricia Moreno; Sandra Souto; Rocio Leiva-Rebollo; Juan J Borrego; Isabel Bandín; M Carmen Alonso
Journal:  Sci Rep       Date:  2019-10-01       Impact factor: 4.379

3.  Infectious Salmon Anemia Virus Infectivity Is Determined by Multiple Segments with an Important Contribution from Segment 5.

Authors:  Matías Cárdenas; Sofía Michelson; Daniel R Pérez; Margarita Montoya; Jorge Toledo; Yesseny Vásquez-Martínez; Marcelo Cortez-San Martin
Journal:  Viruses       Date:  2022-03-18       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.